Table 3a.
Univariate probabilities of outcomes of all patients
| Outcome event | All patients with available outcome data | |
|---|---|---|
| N eval. | Prob (95% CI)a | |
| ANC > 0.5 × 109/L | 111 | |
| @ 28 days | 83 (74-89) | |
| @100 days | 92 (85-96) | |
| Platelets > 20 × 109 /L | 95 | |
| @ 60 days | 57 (46-67) | |
| @100 days | 60 (49-70) | |
| Acute GVHD, Grades 2-4 | 103 | |
| @100 days | 28 (20-37) | |
| @ 180 days | 29 (21-38) | |
| Chronic GVHD | 112 | |
| @ 1 year | 14 (8-21) | |
| @ 3 years | 15 (9-22) | |
| @5 years | 15 (9-22) | |
| Transplant-related mortality | 115 | |
| @ 100days | 18 (12-26) | |
| @ 1 year | 25 (17-33) | |
| @ 3 years | 25 (18-34) | |
| @ 5 years | 25 (18-34) | |
| Relapse | 115 | |
| @ 1 year | 38 (29-47) | |
| @ 3 years | 52 (42-61) | |
| @ 5 years | 55 (45-64) | |
| Disease-free survival | 115 | |
| @ 1 year | 37 (28-46) | |
| @ 3 years | 23 (15-31) | |
| @ 5 years | 20 (13-27) | |
| Overall survival | 143 | |
| @ 1 year | 56 (47-64) | |
| @ 3 years | 29 (22-37) | |
| @ 5 years | 22 (15-30) | |